MakroCare awarded a large cancer registry program a promising US biotech company
MakroCare has been selected by a growing US biotech company for a registry program to create around 1500 cancer patient data. MakroCare, specialized in RWE and outcomes research, has been engaged to offer services for protocol design/writing, data collection, data monitoring, analysis, and reports. MakroCare will also be providing its proprietary technology platform for individual site branding, data collection & review, analytics consisting of 100 sites. In addition, MakroCare will be working with sponsor to design, and launch site specific websites for physicians to keep them updated with published data, news & notifications throughout this program.The objective of this registry is to collect real-world data focusing on treatment decision impact, outcomes in the management of cancer patients and clinical utilization of the diagnostic platform in various cancer patients. This multicenter, non-randomized, single arm, real-world data collection registry is expected to enroll around 1500+ patients over next several years. Some of the key outcomes of this registry would be clinical utilization pattern, treatment-decision impact, clinical benefits rate and objective response rate.
As RWE and outcomes research are becoming increasingly important and necessary for product development and commercialization, MakroCare brings to table technology integrated, cost efficient, non-traditional solutions to support companies in this space.
MakroCare is a leading biotech, pharma and medical device consulting for Clinical Development, Regulatory affairs, Regulatory Operation, Publishing, Labeling, Med Affairs, Central Monitoring and RBM services.
650 College Road East ,Suite 3600 , Princeton, NJ -08540-US
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MakroCare awarded a large cancer registry program a promising US biotech company here
News-ID: 694339 • Views: …
More Releases from MakroCare
Global TOP 5 Pharma Company awarded Regulatory Digitization to MakroCare
Recognizing the unique benefit MakroCare brings in combining functional expertise with technology, a global TOP 5 Pharma selected MakroCare for their strategic regulatory transformation program. In order to support them for next several years to come in various regulatory areas, this digitization and centralization initiatives taken up by this client.
MakroCare combined Regulatory / CMC functional expertise with proprietary technology to digitize last 3 decades of legacy dossiers and extract meaningful…
A Global TOP 10 Medical Device Company Selected MakroCare
MakroCare got selected by a global Top 10 medical device company for upcoming MDR and Rev 4 compliance program. With major changes anticipated for upcoming MDR, this global company knew well an external partner who can align well with their overall goals to help them meet short and long-term goals is vital for their strategy. To start with, to meet current compliance needs of Rev 4 clinical evaluation, a set…
More Releases for RWE
Real-World Evidence (RWE) Solutions Market Worth $4.4 Billion by 2028
According to a new market research report titled "RWE Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, Integrated], Services), Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) - Global Forecast to 2028", published by Meticulous Research®, the real-world evidence solutions market is expected to grow at a CAGR of 11.8% from 2021-2028 to reach $4.4 billion by 2028.
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4954
Real-world evidence…
Real-World Evidence (RWE) Oncology Market Worth $1.65 Billion by 2029
According to a new market research report titled, 'RWE Oncology Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post-market Surveillance), and End User (Pharma, Payer) - Global Forecast to 2029,' published by Meticulous Research®, the real-world evidence oncology solutions market is expected to grow at a CAGR of 14.2% from 2022-2029 to reach $1.65 billion by 2029.
Download Free Sample Report…
Nuclear Power Plant Market Next Big Thing | Kepco, Magnox, RWE, Entergy
Nuclear power plant (NPP) uses nuclear fission reaction to heat water to produce steam which runs the turbines to generate electricity. The fission process occurs inside the reactor where uranium fuel is stored in its core. Considering the high fuel to output ratio produced by these power plants, countries are heavily investing in development of nuclear power plant. United States accounts for 20% of their total electricity production through nuclear…
Global Waste Gas Treatment Equipments Market 2018: RWE, VTU Engineering, Ceramat …
Global Waste Gas Treatment Equipments Market 2018-2023
The Research Report gives detailed information of Waste Gas Treatment Equipments Industry Size and Share in globe. The Waste Gas Treatment Equipments Market Report contains data that is collected from various primary and secondary resources. The data collected was validated from the industry analyst which makes the document a useful resource for managers, analysts, industry experts and other to get access and self-analyzed the…
Global Green Energy Market 2016 Duke Energy, Southern Company, RWE Group
MRS Research Group adds“Global Green Energy Market 2016 Share,Size,Trends and Forecast to 2022 Market Research Report”reports to its database.This report provides a strategic analysis of the Green Energy market and the growth estimates for the forecasted period.The market research analyst projects the global Green Energy market to grow at a considerable CAGR,in terms of revenue,over the forecast period.The report will provide the client with market insights and in-depth analysis of…
RWE AG integrates MultiCash Transfer into the group-wide international Payment F …
RWE AG, who can be counted amount Europe’s leading gas and electricity providers continuously optimise its business processes. Part of this activity was to centralize handling of payments within the group to one standard Payment Factory.
Beyond standardizing payments, it was of central significance for RWE to ensure that the solution was as automated as possible and complied with all internal security requirements. Of course, the new system also has to…